Accessibility Menu
 
Kodiak Sciences logo

Kodiak Sciences

(NASDAQ) KOD

Current Price$42.39
Market Cap$2.59B
Since IPO (2018)+311%
5 Year-62%
1 Year+1,929%
1 Month+63%

Kodiak Sciences Financials at a Glance

Market Cap

$2.59B

Revenue (TTM)

$0.00

Net Income (TTM)

$229.97M

EPS (TTM)

$-4.32

P/E Ratio

-9.67

Dividend

$0.00

Beta (Volatility)

2.33 (High)

Price

$42.39

Volume

623,507

Open

$41.22

Previous Close

$42.36

Daily Range

$40.50 - $42.88

52-Week Range

$2.02 - $45.60

KOD: Motley Fool Moneyball Superscore

51

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kodiak Sciences

Industry

Biotechnology

Employees

124

CEO

Victor Perlroth, MD, MBA

Headquarters

Palo Alto, CA 94304, US

KOD Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-149%

Return on Capital

-77%

Return on Assets

-65%

Earnings Yield

-10.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.59B

Shares Outstanding

61.85M

Volume

623.51K

Short Interest

0.00%

Avg. Volume

1.08M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$234.39M

EBITDA

$234.39M

Operating Cash Flow

$136.01M

Capital Expenditure

$506.00K

Free Cash Flow

$136.51M

Cash & ST Invst.

$209.86M

Total Debt

$59.18M

Kodiak Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$19.80M

+396.4%

Gross Margin

0.00%

N/A

Market Cap

$2.59B

N/A

Market Cap/Employee

$23.72M

N/A

Employees

109

N/A

Net Income

$56.74M

-28.6%

EBITDA

$80.96M

-116.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$150.68M

+54.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$47.12M

-21.1%

Short Term Debt

$12.06M

+13.5%

Return on Assets

-65.42%

N/A

Return on Invested Capital

-76.60%

N/A

Free Cash Flow

$39.42M

-30.6%

Operating Cash Flow

$39.38M

-31.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TNGXTango Therapeutics, Inc.
$20.70+3.19%
ANABAnaptysBio, Inc.
$68.54+4.58%
OCSOculis Holding AG
$27.19-0.55%
NRIXNurix Therapeutics, Inc.
$16.24+4.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$61.72+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
NOKNokia
$9.55+0.01%
PLTRPalantir Technologies
$130.49-0.07%

Questions About KOD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.